The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis

被引：0
作者：
Agnes van Sonderen
Mar Petit-Pedrol
Josep Dalmau
Maarten J. Titulaer
机构：
[1] Erasmus University Medical Center,Department of Neurology
[2] Haga Hospital,Department of Neurology
[3] Neuroimmunology Program,Department of Neurology
[4] Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS),undefined
[5] University of Barcelona,undefined
[6] Centro de Investigación Biomédica en Red (CIBER),undefined
[7] Hospital Clinic,undefined
[8] Institució Catalana de Recerca i Estudis Avançats (ICREA),undefined
[9] University of Pennsylvania,undefined
来源：
Nature Reviews Neurology | 2017年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Three groups of voltage-gated potassium channel (VGKC) antibody-positive patients should be distinguished: patients with antibodies against leucine-rich glioma-inactivated 1 (LGI1), patients with antibodies against contactin-associated protein-like 2 (Caspr2), and patients lacking both of these antibodiesPatients with anti-LGI1 antibodies usually present with typical limbic encephalitis, including alteration of memory and behaviour, spatial disorientation and several types of seizuresPatients with anti-Caspr2 antibodies present with various syndromes that involve the CNS and/or PNS, which mainly consist of cognitive decline, epilepsy and peripheral nerve hyperexcitabilityPatients with antibodies against LGI1 or Caspr2 usually respond well to immunotherapyThe clinical relevance of antibodies against the VGKC complex that lack reactivity against LGI1 and Caspr2 is uncertain; in patients with these antibodies, clinical assessment and ancillary tests prevail for the establishment of a diagnosis and formulation of treatment
引用
收藏
页码：290 / 301
页数：11
相关论文
共 134 条
[31]  
Arino H(2016)Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre Brain 139 1079-673
[32]  
Irani SR(2014)VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy Seizure 23 670-181
[33]  
Bien CG(2006)Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis Ann. Neurol. 59 178-59
[34]  
Gao L(2017)Pilomotor seizures: an autonomic semiology of limbic encephalitis? JAMA Neurol. 74 50-1357
[35]  
Irani SR(2015)Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis Neurol. Neuroimmunol. Neuroinflamm. 2 e161-e160
[36]  
Li Z(2011)Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies Neurology 76 1355-1705
[37]  
Cui T(2016)Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures Epilepsia 57 e155-3162
[38]  
Shi W(2014)Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis? J. Neurol. 261 1695-1161
[39]  
Wang Q(2013)Subclinical temporal EEG seizure pattern in LGI1-antibody-mediated encephalitis Brain 136 3151-900
[40]  
Olberg H(2015)Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity Eur. J. Neurol. 22 1151-975
12345678910